Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study

Response to comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma’

(2014) T M Meniawy et al.   BRITISH JOURNAL OF CANCER

Comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma’

(2014) S C-H Kao et al.   BRITISH JOURNAL OF CANCER

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma

(2014) B Ghanim et al.   BRITISH JOURNAL OF CANCER

PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy

(2014) Byron K.Y. Bitanihirwe et al.   Journal of Thoracic Oncology

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma

(2013) T M Meniawy et al.   BRITISH JOURNAL OF CANCER

Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)

(2013) Dario Baratti et al.   EUROPEAN JOURNAL OF CANCER

Pretreatment Serum C-Reactive Protein Levels Predict Benefit From Multimodality Treatment Including Radical Surgery in Malignant Pleural Mesothelioma

(2012) Bahil Ghanim et al.   ANNALS OF SURGERY

Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group

(2012) Aliya N. Husain et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma

(2012) Kyuichi Kadota et al.   MODERN PATHOLOGY

Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy

(2011) Steven Chuan-Hao Kao et al.   Journal of Thoracic Oncology

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) R. A. Stahel et al.   ANNALS OF ONCOLOGY

The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions

(2010) Farnaz Hasteh et al.   CANCER CYTOPATHOLOGY

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy

(2010) S. C. H. Kao et al.   CLINICAL CANCER RESEARCH

Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry

(2010) Helmut P Sandeck et al.   Diagnostic Pathology

ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on Survival

(2010) Birgit Guldhammer Skov et al.   Journal of Thoracic Oncology

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

A Clinical, Radiographic and Laboratory Evaluation of Prognostic Factors in 363 Patients with Malignant Pleural Mesothelioma

(2010) Abdullah Cetin Tanrikulu et al.   RESPIRATION

Surgery for malignant pleural mesothelioma

(2010) David J Sugarbaker et al.   Expert Review of Respiratory Medicine

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

(2009) A. Scherpereel et al.   EUROPEAN RESPIRATORY JOURNAL

Malignant Pleural Mesothelioma

(2009) Anne S. Tsao et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma

(2008) Clemens Aigner et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY